Daniel Carpenter News
Most Popular Daniel Carpenter Story
Study reaffirms safety flags for last-minute meds
Remember that study that seemed to show that drugs FDA approved on deadline were more likley to end up with safety problems? Since its March publication in the New England Journal of Medicine, FDA Read more...
Latest Headlines
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
